Antipsychotic Dosing: How Much but also How Often?
Remington and Kapur
Schizophr Bull 2010;36:900-903.
ABSTRACT
| FULL TEXT
Low-dose quetiapine for patients with dysregulation of hyperthymic and cyclothymic temperaments
Bisol and Lara
J Psychopharmacol 2010;24:421-424.
ABSTRACT
The Effect of Antipsychotics on the High-Affinity State of D2 and D3 Receptors: A Positron Emission Tomography Study With [11C]-(+)-PHNO
Graff-Guerrero et al.
Arch Gen Psychiatry 2009;66:606-615.
ABSTRACT
| FULL TEXT
Pharmacokinetics and time-course of D2 receptor occupancy induced by atypical antipsychotics in stabilized schizophrenic patients
Catafau et al.
J Psychopharmacol 2008;22:882-894.
ABSTRACT
Brain and Plasma Pharmacokinetics of Aripiprazole in Patients With Schizophrenia: An [18F]Fallypride PET Study
Grunder et al.
Am. J. Psychiatry 2008;165:988-995.
ABSTRACT
| FULL TEXT
Prolactin and dopamine: What is the connection? A Review Article
Fitzgerald and Dinan
J Psychopharmacol 2008;22:12-19.
ABSTRACT
Possible intranasal quetiapine misuse
Morin
Am J Health Syst Pharm 2007;64:723-725.
ABSTRACT
| FULL TEXT
The role of emission tomography in pharmacokinetic and pharmacodynamic studies in clinical psychopharmacology
Malizia
J Psychopharmacol 2006;20:100-107.
ABSTRACT
Equivalent Occupancy of Dopamine D1 and D2 Receptors With Clozapine: Differentiation From Other Atypical Antipsychotics
Tauscher et al.
Am. J. Psychiatry 2004;161:1620-1625.
ABSTRACT
| FULL TEXT
Worsening Schizoaffective Disorder With Aripiprazole
REEVES and MACK
Am. J. Psychiatry 2004;161:1308-1308.
FULL TEXT
A PET Study of Dopamine D2 and Serotonin 5-HT2 Receptor Occupancy in Patients With Schizophrenia Treated With Therapeutic Doses of Ziprasidone
Mamo et al.
Am. J. Psychiatry 2004;161:818-825.
ABSTRACT
| FULL TEXT
Atypical antipsychotic drugs and tardive dyskinesia: relevance of D2 receptor affinity
Bressan et al.
J Psychopharmacol 2004;18:124-127.
ABSTRACT
Low dose quetiapine for drug induced dyskinesias in Parkinson's disease: a double blind cross over study
Katzenschlager et al.
J. Neurol. Neurosurg. Psychiatry 2004;75:295-297.
ABSTRACT
| FULL TEXT
Atypical Antipsychotics: Mechanism of Action
Seeman
Focus 2004;2:48-58.
ABSTRACT
| FULL TEXT
Mechanism of New Antipsychotic Medications: Occupancy Is Not Just Antagonism
Grunder et al.
Arch Gen Psychiatry 2003;60:974-977.
ABSTRACT
| FULL TEXT
Effectiveness of Switching to Quetiapine for Neuroleptic-Induced Amenorrhea
Takahashi et al.
J Neuropsychiatry Clin Neurosci 2003;15:375-377.
ABSTRACT
| FULL TEXT
Antipsychotic Dosing in Preclinical Models Is Often Unrepresentative of the Clinical Condition: A Suggested Solution Based on in Vivo Occupancy
Kapur et al.
J. Pharmacol. Exp. Ther. 2003;305:625-631.
ABSTRACT
| FULL TEXT
Resolution of Risperidone-Induced Hyperprolactinemia with Substitution of Quetiapine
Kunwar and Megna
The Annals of Pharmacotherapy 2003;37:206-208.
ABSTRACT
| FULL TEXT
Dopamine and antipsychotic drug action revisited
JONES and PILOWSKY
Br. J. Psychiatry 2002;181:271-275.
FULL TEXT
Quetiapine for Olanzapine-Induced Galactorrhea
KINGSBURY et al.
Am. J. Psychiatry 2002;159:1061-1061.
FULL TEXT
Elevation of Prolactin Levels by Atypical Antipsychotics
Turrone et al.
Am. J. Psychiatry 2002;159:133-135.
ABSTRACT
| FULL TEXT
Use of Quetiapine in Delirium: Case Reports
Torres et al.
Psychosomatics 2001;42:347-349.
FULL TEXT
Does Fast Dissociation From the Dopamine D2 Receptor Explain the Action of Atypical Antipsychotics?: A New Hypothesis
Kapur and Seeman
Am. J. Psychiatry 2001;158:360-369.
ABSTRACT
| FULL TEXT